EssilorLuxottica Société anonyme Past Earnings Performance
Past criteria checks 3/6
EssilorLuxottica Société anonyme has been growing earnings at an average annual rate of 27.9%, while the Medical Equipment industry saw earnings growing at 27.9% annually. Revenues have been growing at an average rate of 12.5% per year. EssilorLuxottica Société anonyme's return on equity is 6.5%, and it has net margins of 8.7%.
Key information
27.87%
Earnings growth rate
27.13%
EPS growth rate
| Medical Equipment Industry Growth | 21.56% |
| Revenue growth rate | 12.46% |
| Return on equity | 6.54% |
| Net Margin | 8.74% |
| Last Earnings Update | 30 Jun 2025 |
Recent past performance updates
Recent updates
Estimating The Intrinsic Value Of EssilorLuxottica Société anonyme (EPA:EL)
Aug 16
The EssilorLuxottica Société anonyme (EPA:EL) Half-Yearly Results Are Out And Analysts Have Published New Forecasts
Aug 01Risks To Shareholder Returns Are Elevated At These Prices For EssilorLuxottica Société anonyme (EPA:EL)
Jul 06Is EssilorLuxottica Société anonyme (EPA:EL) Using Too Much Debt?
Jun 17Estimating The Intrinsic Value Of EssilorLuxottica Société anonyme (EPA:EL)
May 17EssilorLuxottica Société anonyme's (EPA:EL) Dividend Will Be €3.95
Apr 23There's Been No Shortage Of Growth Recently For EssilorLuxottica Société anonyme's (EPA:EL) Returns On Capital
Apr 14EssilorLuxottica Société anonyme (EPA:EL) Has Affirmed Its Dividend Of €3.95
Apr 01Should You Think About Buying EssilorLuxottica Société anonyme (EPA:EL) Now?
Apr 01EssilorLuxottica Société anonyme (EPA:EL) Is Due To Pay A Dividend Of €3.95
Mar 18
Expansion Into Smart Glasses And Med-Tech May Boost Future Earnings Despite High PE Ratios
Strategic expansion in smart glasses and med-tech could drive revenue growth and improve net margins through higher profit margins and innovative products.Investors Appear Satisfied With EssilorLuxottica Société anonyme's (EPA:EL) Prospects As Shares Rocket 27%
Feb 14Calculating The Fair Value Of EssilorLuxottica Société anonyme (EPA:EL)
Feb 06Here's Why EssilorLuxottica Société anonyme (EPA:EL) Can Manage Its Debt Responsibly
Dec 29Is There Now An Opportunity In EssilorLuxottica Société anonyme (EPA:EL)?
Dec 15Returns On Capital Are Showing Encouraging Signs At EssilorLuxottica Société anonyme (EPA:EL)
Dec 01Calculating The Intrinsic Value Of EssilorLuxottica Société anonyme (EPA:EL)
Nov 03Investors Interested In EssilorLuxottica Société anonyme's (EPA:EL) Earnings
Oct 21Is EssilorLuxottica Société anonyme (EPA:EL) Using Too Much Debt?
Sep 23Revenue & Expenses Breakdown
How EssilorLuxottica Société anonyme makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 25 | 27,242 | 2,381 | 12,712 | 648 |
| 31 Mar 25 | 26,875 | 2,370 | 12,590 | 640 |
| 31 Dec 24 | 26,508 | 2,359 | 12,467 | 631 |
| 30 Sep 24 | 26,171 | 2,326 | 12,352 | 617 |
| 30 Jun 24 | 25,834 | 2,293 | 12,218 | 602 |
| 31 Mar 24 | 25,615 | 2,291 | 12,135 | 598 |
| 31 Dec 23 | 25,395 | 2,289 | 12,051 | 593 |
| 30 Sep 23 | 25,373 | 2,314 | 12,039 | 604 |
| 30 Jun 23 | 25,351 | 2,339 | 12,026 | 614 |
| 31 Mar 23 | 24,923 | 2,246 | 11,847 | 607 |
| 31 Dec 22 | 24,494 | 2,152 | 11,668 | 600 |
| 30 Sep 22 | 23,770 | 1,960 | 11,409 | 588 |
| 30 Jun 22 | 23,046 | 1,768 | 11,150 | 575 |
| 31 Mar 22 | 21,433 | 1,608 | 10,193 | 577 |
| 31 Dec 21 | 19,820 | 1,448 | 9,235 | 579 |
| 30 Sep 21 | 18,394 | 1,400 | 8,333 | 575 |
| 30 Jun 21 | 16,967 | 1,351 | 7,430 | 571 |
| 31 Mar 21 | 15,698 | 718 | 7,240 | 562 |
| 31 Dec 20 | 14,429 | 85 | 7,049 | 552 |
| 30 Sep 20 | 14,637 | 40 | 7,209 | 551 |
| 30 Jun 20 | 14,844 | -6 | 7,369 | 550 |
| 31 Mar 20 | 16,117 | 536 | 7,727 | 549 |
| 31 Dec 19 | 17,390 | 1,077 | 8,085 | 548 |
| 30 Sep 19 | 16,215 | 1,151 | 7,629 | 489 |
| 30 Jun 19 | 15,040 | 1,224 | 7,172 | 430 |
| 31 Mar 19 | 12,937 | 1,154 | 6,108 | 310 |
| 31 Dec 18 | 10,833 | 1,083 | 5,044 | 190 |
| 30 Sep 18 | 10,364 | 1,132 | 5,057 | 85 |
| 30 Jun 18 | 9,894 | 1,181 | 5,069 | -21 |
| 31 Mar 18 | 9,539 | 1,111 | 4,605 | 20 |
| 31 Dec 17 | 9,184 | 1,040 | 4,141 | 60 |
| 30 Sep 17 | 8,288 | 913 | 3,011 | 138 |
| 30 Jun 17 | 7,391 | 786 | 1,881 | 216 |
| 31 Mar 17 | 7,253 | 800 | 1,848 | 215 |
| 31 Dec 16 | 7,115 | 813 | 1,814 | 214 |
| 30 Sep 16 | 7,003 | 799 | 1,799 | 216 |
| 30 Jun 16 | 6,891 | 785 | 1,783 | 218 |
| 31 Mar 16 | 6,804 | 771 | 1,755 | 216 |
| 31 Dec 15 | 6,716 | 757 | 1,727 | 214 |
| 30 Sep 15 | 6,507 | 688 | 1,664 | 208 |
| 30 Jun 15 | 6,298 | 618 | 1,601 | 202 |
| 31 Mar 15 | 5,984 | 774 | 1,504 | 195 |
| 31 Dec 14 | 5,670 | 929 | 1,406 | 188 |
| 30 Sep 14 | 5,470 | 956 | 1,326 | 181 |
Quality Earnings: EL has high quality earnings.
Growing Profit Margin: EL's current net profit margins (8.7%) are lower than last year (8.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EL has become profitable over the past 5 years, growing earnings by 27.9% per year.
Accelerating Growth: EL's earnings growth over the past year (3.8%) is below its 5-year average (27.9% per year).
Earnings vs Industry: EL earnings growth over the past year (3.8%) exceeded the Medical Equipment industry 1.1%.
Return on Equity
High ROE: EL's Return on Equity (6.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/29 17:36 |
| End of Day Share Price | 2025/08/29 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
EssilorLuxottica Société anonyme is covered by 55 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hubert D'Aillieres | Banco BPI, S.A. |
| null null | Banco de Sabadell. S.A. |
| Alexander Kleban | Barclays |